Pathology of High-Mitotic Rate Melanoma Identified

Share this content:
High-mitotic-rate tumors present more often as amelanotic, rapidly growing lesions.
High-mitotic-rate tumors present more often as amelanotic, rapidly growing lesions.

High-mitotic-rate primary cutaneous melanomas more often occur on the head and neck and in men, older patients, and those with a history of solar keratosis, according to a study published online in JAMA Dermatology.

Sarah Shen, M.B.B.S., from the Alfred Hospital in Melbourne, Australia, and colleagues conducted a cross-sectional study of patients from a multidisciplinary melanoma clinic to examine the clinicopathological associations of high-mitotic-rate melanoma. Data were included for 1,441 patients with 1,500 primary invasive melanomas.

The researchers found that high-mitotic-rate melanomas were more likely to occur in men, patients aged 70 years or older, and those with a history of solar keratosis (odds ratios [ORs], 1.5, 2.1, and 1.3, respectively). These melanomas were more likely to occur on the head and neck (OR, 1.4) and more often presented as amelanotic and rapidly growing (≥2 mm/month) lesions (ORs, 1.9 and 12.5, respectively).

RELATED: Incidence and Recurrence of Melanoma Are Equivalent

A higher mitotic rate was associated with nodular melanoma subtype (versus superficial spreading), greater tumor thickness (versus ≤1 mm), and ulceration. In the overall multivariate analysis, these histopathological features remained significant, together with amelanosis and rate of growth.

"High-mitotic-rate primary cutaneous melanoma is associated with aggressive histologic features and atypical clinical presentation," the authors write.

  1. Shen, Sarah, MBBS, BMedSci, et al. "Characteristics and Associations of High-Mitotic-Rate Melanoma." JAMA Dermatology. doi:10.1001/jamadermatol.2014.635. August 20, 2014.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs